Web Analysis for Exjade - exjade.com
Learn about EXJADE®, an iron chelation therapy for the management of chronic iron overload due to blood transfusions. See safety & product information.
2.50
Rating by CuteStat
exjade.com is 2 decades 2 years old. It is a domain having com extension. It has a global traffic rank of #9205258 in the world. This website is estimated worth of $ 240.00 and have a daily income of around $ 1.00. As no active threats were reported recently by users, exjade.com is SAFE to browse.
PageSpeed Score
0
Siteadvisor Rating
No Risk Issues
Traffic Report
| Daily Unique Visitors: | 91 |
| Daily Pageviews: | 182 |
Estimated Valuation
| Income Per Day: | $ 1.00 |
| Estimated Worth: | $ 240.00 |
Search Engine Indexes
| Google Indexed Pages: | 16 |
| Bing Indexed Pages: | Not Applicable |
Search Engine Backlinks
| Google Backlinks: | 243,000 |
| Bing Backlinks: | Not Applicable |
Safety Information
| Google Safe Browsing: | No Risk Issues |
| Siteadvisor Rating: | No Risk Issues |
| WOT Trustworthiness: | Not Applicable |
| WOT Child Safety: | Not Applicable |
Website Ranks & Scores
| Alexa Rank: | 9,205,258 |
| Domain Authority: | Not Applicable |
Web Server Information
Hosted IP Address:
217.114.92.50
Hosted Country:
SE
Location Latitude:
59.3247Location Longitude:
18.056Page Resources Breakdown
Homepage Links Analysis
Website Inpage Analysis
| H1 Headings: | 1 | H2 Headings: | Not Applicable |
| H3 Headings: | Not Applicable | H4 Headings: | 1 |
| H5 Headings: | Not Applicable | H6 Headings: | Not Applicable |
| Total IFRAMEs: | 1 | Total Images: | 8 |
| Google Adsense: | Not Applicable | Google Analytics: | Not Applicable |
Websites Hosted on Same IP (i.e. 217.114.92.50)
AFINITOR® (everolimus) | Official Site from Novartis
The official website for AFINITOR® (everolimus) tablets. Find information about AFINITOR®, the conditions it treats, and Important Safety Information.
2,946,082
$
480.00
SANDOSTATIN® LAR Depot (octreotide acetate) for Acromegaly and Carcino
Learn about SANDOSTATIN® LAR Depot (octreotide acetate) for injectable suspension for acromegaly and carcinoid syndrome. See Important Safety Information.
Not Applicable
$
8.95
FEMARA® (letrozole) | 1L Treatment for HR+ Metastatic Breast Cancer
Discover FEMARA® (letrozole), an approved treatment from Novartis Oncology for HR+ breast cancer in postmenopausal women. Learn about FEMARA® side effects & see recommended FEMARA® dosage information.
Not Applicable
$
8.95
TYKERB® (lapatinib) | HR+, HER2+ Metastatic Breast Cancer
Learn about TYKERB® (lapatinib), approved to treat HR+ and HER2+ metastatic breast cancer. Find Important Safety Information and BOXED WARNING.
5,943,198
$
240.00
HTTP Header Analysis
HTTP/1.0 200 OK
Cache-Control: private
Content-Type: text/html; charset=utf-8
Date: Sat, 14 Dec 2019 08:04:24 GMT
Server: ECAcc (saa/83DD)
Strict-Transport-Security: max-age=31536000; includeSubDomains
Via: 1.1 sjc1-bit18
X-Content-Type-Options: nosniff
X-Frame-Options: SAMEORIGIN
X-XSS-Protection: 1; mode=block
Content-Length: 22198
Connection: close
Cache-Control: private
Content-Type: text/html; charset=utf-8
Date: Sat, 14 Dec 2019 08:04:24 GMT
Server: ECAcc (saa/83DD)
Strict-Transport-Security: max-age=31536000; includeSubDomains
Via: 1.1 sjc1-bit18
X-Content-Type-Options: nosniff
X-Frame-Options: SAMEORIGIN
X-XSS-Protection: 1; mode=block
Content-Length: 22198
Connection: close
Domain Information
| Domain Registrar: |
MarkMonitor, Inc.
|
|---|---|
| Registration Date: | Oct 23, 2001, 12:45 PM 2 decades 2 years 6 months ago |
| Expiration Date: | Oct 23, 2021, 12:45 PM 2 years 6 months 1 week ago |
| Domain Status: |
clientupdateprohibited
clienttransferprohibited
clientdeleteprohibited
|
Domain Nameserver Information
| Host | IP Address | Country | |
|---|---|---|---|
| dns1.novartis.com |
|
160.62.4.7 |
Switzerland
|
| dns2.novartis.com |
|
160.62.7.59 |
Switzerland
|
| dns3.novartis.com |
|
160.62.14.115 |
United States of America
|
| dns4.novartis.com |
|
160.62.14.116 |
United States of America
|
DNS Record Analysis
| Host | Type | TTL | Extra |
|---|---|---|---|
| exjade.com | A | 10798 |
IP: 217.114.92.50 |
| exjade.com | NS | 86400 |
Target: dns4.novartis.com |
| exjade.com | NS | 86400 |
Target: dns1.novartis.com |
| exjade.com | NS | 86400 |
Target: dns2.novartis.com |
| exjade.com | NS | 86400 |
Target: dns3.novartis.com |
| exjade.com | SOA | 3600 |
MNAME: dns1.novartis.com RNAME: hostmaster.novartis.com Serial: 2019062001 Refresh: 28800 Retry: 7200 Expire: 604800 Minimum TTL: 3600 |
| exjade.com | TXT | 86400 |
TXT: a3470533-c74a-4afa-a85b-471a8424fd7c |
Similarly Ranked Websites
รู้ทันโรคปลอดภัยห่างไกลโรค | ดูแลรักษาและป้องกันการเกิดโรคอย่างถูกวิธี
9,205,274
$
240.00
Fastrack Dealer Network
The only genuine, reliable source of actual sold data for truck, agriculture, earthmoving and material handling industries.
9,205,285
$
240.00
รวมเทคนิคความรู้การลงทุนทั้งในประเทศและต่างประเทศ – เว็บไซต์ที่จะมาให้ข้อมูลความรู้เกี่ย
9,205,289
$
240.00
Comprar mejores esteroides y anabólicos en línea para la venta
Esteroides anabólicos en venta con entrega en España y Portugal, Europa. Los mejores fabricantes de esteroides a la venta a un costo razonable.
9,205,300
$
240.00
Full WHOIS Lookup
Domain Name: exjade.com
Registry Domain ID: 78899094_DOMAIN_COM-VRSN
Registrar WHOIS Server: whois.markmonitor.com
Registrar URL: http://www.markmonitor.com
Updated Date: 2019-12-13T00:10:01-0800
Creation Date: 2001-10-23T00:00:00-0700
Registrar Registration Expiration Date: 2021-10-23T00:00:00-0700
Registrar: MarkMonitor, Inc.
Registrar IANA ID: 292
Registrar Abuse Contact Email: abusecomplaints@markmonitor.com
Registrar Abuse Contact Phone: +1.2083895740
Domain Status: clientUpdateProhibited (https://www.icann.org/epp#clientUpdateProhibited)
Domain Status: clientTransferProhibited (https://www.icann.org/epp#clientTransferProhibited)
Domain Status: clientDeleteProhibited (https://www.icann.org/epp#clientDeleteProhibited)
Registrant Organization: Novartis AG
Registrant State/Province:
Registrant Country: CH
Admin Organization: MarkMonitor, Inc.
Admin State/Province: ID
Admin Country: US
Tech Organization: MarkMonitor, Inc.
Tech State/Province: ID
Tech Country: US
Name Server: dns2.novartis.com
Name Server: dns3.novartis.com
Name Server: dns4.novartis.com
Name Server: dns1.novartis.com
DNSSEC: unsigned
URL of the ICANN WHOIS Data Problem Reporting System: http://wdprs.internic.net/
>>> Last update of WHOIS database: 2019-12-14T00:04:30-0800 <<<
For more information on WHOIS status codes, please visit:
https://www.icann.org/resources/pages/epp-status-codes
If you wish to contact this domain’s Registrant, Administrative, or Technical
contact, and such email address is not visible above, you may do so via our web
form, pursuant to ICANN’s Temporary Specification. To verify that you are not a
robot, please enter your email address to receive a link to a page that
facilitates email communication with the relevant contact(s).
Web-based WHOIS:
https://domains.markmonitor.com/whois
If you have a legitimate interest in viewing the non-public WHOIS details, send
your request and the reasons for your request to whoisrequest@markmonitor.com
and specify the domain name in the subject line. We will review that request and
may ask for supporting documentation and explanation.
The data in MarkMonitor’s WHOIS database is provided for information purposes,
and to assist persons in obtaining information about or related to a domain
name’s registration record. While MarkMonitor believes the data to be accurate,
the data is provided "as is" with no guarantee or warranties regarding its
accuracy.
By submitting a WHOIS query, you agree that you will use this data only for
lawful purposes and that, under no circumstances will you use this data to:
(1) allow, enable, or otherwise support the transmission by email, telephone,
or facsimile of mass, unsolicited, commercial advertising, or spam; or
(2) enable high volume, automated, or electronic processes that send queries,
data, or email to MarkMonitor (or its systems) or the domain name contacts (or
its systems).
MarkMonitor.com reserves the right to modify these terms at any time.
By submitting this query, you agree to abide by this policy.
MarkMonitor is the Global Leader in Online Brand Protection.
MarkMonitor Domain Management(TM)
MarkMonitor Brand Protection(TM)
MarkMonitor AntiCounterfeiting(TM)
MarkMonitor AntiPiracy(TM)
MarkMonitor AntiFraud(TM)
Professional and Managed Services
Visit MarkMonitor at https://www.markmonitor.com
Contact us at +1.8007459229
In Europe, at +44.02032062220
Registry Domain ID: 78899094_DOMAIN_COM-VRSN
Registrar WHOIS Server: whois.markmonitor.com
Registrar URL: http://www.markmonitor.com
Updated Date: 2019-12-13T00:10:01-0800
Creation Date: 2001-10-23T00:00:00-0700
Registrar Registration Expiration Date: 2021-10-23T00:00:00-0700
Registrar: MarkMonitor, Inc.
Registrar IANA ID: 292
Registrar Abuse Contact Email: abusecomplaints@markmonitor.com
Registrar Abuse Contact Phone: +1.2083895740
Domain Status: clientUpdateProhibited (https://www.icann.org/epp#clientUpdateProhibited)
Domain Status: clientTransferProhibited (https://www.icann.org/epp#clientTransferProhibited)
Domain Status: clientDeleteProhibited (https://www.icann.org/epp#clientDeleteProhibited)
Registrant Organization: Novartis AG
Registrant State/Province:
Registrant Country: CH
Admin Organization: MarkMonitor, Inc.
Admin State/Province: ID
Admin Country: US
Tech Organization: MarkMonitor, Inc.
Tech State/Province: ID
Tech Country: US
Name Server: dns2.novartis.com
Name Server: dns3.novartis.com
Name Server: dns4.novartis.com
Name Server: dns1.novartis.com
DNSSEC: unsigned
URL of the ICANN WHOIS Data Problem Reporting System: http://wdprs.internic.net/
>>> Last update of WHOIS database: 2019-12-14T00:04:30-0800 <<<
For more information on WHOIS status codes, please visit:
https://www.icann.org/resources/pages/epp-status-codes
If you wish to contact this domain’s Registrant, Administrative, or Technical
contact, and such email address is not visible above, you may do so via our web
form, pursuant to ICANN’s Temporary Specification. To verify that you are not a
robot, please enter your email address to receive a link to a page that
facilitates email communication with the relevant contact(s).
Web-based WHOIS:
https://domains.markmonitor.com/whois
If you have a legitimate interest in viewing the non-public WHOIS details, send
your request and the reasons for your request to whoisrequest@markmonitor.com
and specify the domain name in the subject line. We will review that request and
may ask for supporting documentation and explanation.
The data in MarkMonitor’s WHOIS database is provided for information purposes,
and to assist persons in obtaining information about or related to a domain
name’s registration record. While MarkMonitor believes the data to be accurate,
the data is provided "as is" with no guarantee or warranties regarding its
accuracy.
By submitting a WHOIS query, you agree that you will use this data only for
lawful purposes and that, under no circumstances will you use this data to:
(1) allow, enable, or otherwise support the transmission by email, telephone,
or facsimile of mass, unsolicited, commercial advertising, or spam; or
(2) enable high volume, automated, or electronic processes that send queries,
data, or email to MarkMonitor (or its systems) or the domain name contacts (or
its systems).
MarkMonitor.com reserves the right to modify these terms at any time.
By submitting this query, you agree to abide by this policy.
MarkMonitor is the Global Leader in Online Brand Protection.
MarkMonitor Domain Management(TM)
MarkMonitor Brand Protection(TM)
MarkMonitor AntiCounterfeiting(TM)
MarkMonitor AntiPiracy(TM)
MarkMonitor AntiFraud(TM)
Professional and Managed Services
Visit MarkMonitor at https://www.markmonitor.com
Contact us at +1.8007459229
In Europe, at +44.02032062220
